Archive: Nov 2019

New migraine medication passes clinical trial

A new migraine medication called ubrogepant recently passed a large scale phase 3 clinical trial. This medication may be able to help treat patients that cannot tolerate or do not respond to the most common types of migraine medication.

Learning to Remember: Memory-Trace Cells

Electrical recordings from human subjects have revealed the existence of memory-trace cells, which change their response depending on which previous experience is supposed to be recalled, providing a major insight into how the brain remembers specific…

Virtual Clinical Trials: Testing new drugs from afar

by Isabella Grabski figures by Jovana Andrejevic Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and…

Racial Minorities Face a Dearth of Stem Cell Donors

by Jordan Wilkerson figures by Nicholas Lue Desimond Viray is a Californian in his early ‘30s. He works in IT support for Jelly Belly Candy Company and lives with his wife and four children. Ten years ago, he was diagnosed with a rare form of blood…

Treating Down Syndrome By Treating Stress

Researchers recently showed that stress response controlling protein synthesis in the brain contributes to the cognitive disability in Down Syndrome, and by inhibiting this response, the cognitive defects in mice with Down Syndrome is reversed. Read Wei…